Dx Deals: Outreach Deals by Quest, Labcorp Are Still Ramping Up
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains
Recently announced collaboration between Viome and Henry Schein allows dentists to offer sample collection for Viome’s assay to patients
Partnership between Mindera and PBM aims to optimize treatment matches for the disorder, as some drugs cost nearly six figures annually
Both companies have made recent moves to diversify further.
More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
As is usual at this time of year, deals in the diagnostics industry were up, both in terms of volume and value.
Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.
A strategic partnership with Google enables more accurate whole genome sequencing with machine learning.
Release of second-generation Cologuard test data and recently announced partnerships aim to position company well for the future.